-
Devang_eng
- President of Anioplex, LLC, a global strategy, business, and technical advisory firm serving startups, multinational corporations, venture capital firms and universities
- Research expertise in regenerative medicine, stem cells, and gene therapy and biomaterials at Harvard Medical School, Kyoto University and UCLA
- Ph.D in Biomedical Engineering from UCLA; currently studying law at Santa Clara University, with J.D. and California attorney license expected in 2020
-
Ikeno_Eng
- Currently serves as a Chief Medical Officer at Medventure Partners, Inc.
- Works as a research associate of cardiovascular medicine at Stanford University where he is responsible for preclinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases
- Visiting Professor at T-CReDO (Tsukuba Clinical Research & Development Organization) since 2019
-
Phillip_eng
- Directs the Cardiovascular Stem Cell Laboratory and Stanford Cardiothoracic MRI Program
- Research interest focuses on translational effort of iPSC-derived small molecules for cardiovascular restoration
- Received BAS and MA from Stanford University and M.D. from Yale University School of Medicine, and completed post-graduate training at UCLA and Stanford University Medical Centers